Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lahuerta, J.J. (Juan José)"'
Autor:
Ríos-Tamayo, R. (Rafael), Paiva, B. (Bruno), Lahuerta, J.J. (Juan José), Martínez-López, J. (Joaquín), Duarte, R.F. (Rafael F.)
Simple Summary Monoclonal gammopathy of clinical significance (MGCS) refers to a recently coined term describing a complex and heterogeneous group of nonmalignant monoclonal gammopathies. These patients are characterized by the presence of a commonly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::7fffc8421f1df1f5947def830bfad62c
https://hdl.handle.net/10171/65307
https://hdl.handle.net/10171/65307
Autor:
Burgos, L. (Leire), Puig, N. (Noemí), Cedena, M.T. (María Teresa), Lahuerta, J.J. (Juan José), Paiva, B. (Bruno), San-Miguel, J.F. (Jesús F.)
The landscape of multiple myeloma (MM) has changed considerably in the past two decades regarding new treatments, insight into disease biology and innovation in the techniques available to assess measurable residual disease (MRD) as the most accurate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::5bbbf829726c577bfe1920e9211c7d27
https://hdl.handle.net/10171/66070
https://hdl.handle.net/10171/66070
Autor:
Aranaz-Oroz, P. (Paula), Paiva, B. (Bruno), Cedena, M.T. (María Teresa), Puig, N. (Noemí), Cordón, L. (Lourdes), Vidriales, M.B. (María Belén), Gutierrez, N.C. (Norma C.), Chiodi, F. (Francesca), Burgos, L. (Leire), Lopez-Anglada, L. (Lucia), Martínez-López, J. (Joaquín), Hernandez, M.T. (Miguel Teodoro), Teruel, A.I. (Ana Isabel), Gironella, M. (Mercedes), Echeveste, M.A. (Maria Asuncion), Rosiñol, L. (Laura), Martínez, R. (Rafael), Oriol, A. (Albert), Rubia, J. (Javier) de la, Orfao, A. (Alberto), Bladé, J. (Joan), Lahuerta, J.J. (Juan José), Mateos, M.V. (María Victoria), San-Miguel, J.F. (Jesús F.)
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
Persistence of minimal residual disease (MRD) after treatment for myeloma predicts inferior outcomes, but within MRD-positive patients there is great heterogeneity with both early and very late relapses. Among different MRD techniques, flow cytometry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e8c377dc59ced930ddd3b83c2d1baefe
https://hdl.handle.net/10171/52011
https://hdl.handle.net/10171/52011
Autor:
Paiva, B. (Bruno), Cedena, M.T. (María Teresa), Puig, N. (Noemí), Arana, P. (Paula), Vidriales, M.B. (María Belén), Cordón, L. (Lourdes), Flores-Montero, J. (Juan), Gutierrez, N.C. (Norma C.), Martin-Ramos, M.L. (Maria Luisa), Martínez-López, J. (Joaquín), Ocio, E.M. (Enrique M.), Hernandez, M.T. (Miguel Teodoro), Teruel, A.I. (Ana Isabel), Rosiñol, L. (Laura), Echeveste, M.A. (Maria Asuncion), Martínez, R. (Rafael), Gironella, M. (Mercedes), Oriol, A. (Albert), Cabrera, C. (Carmen), Martin, J. (Jesus), Bargay, J. (Joan), Encinas, C. (Cristina), Gonzalez, Y. (Yolanda), Dongen, J.J.M. (Jacques J. M.) van, Orfao, A. (Alberto), Bladé, J. (Joan), Mateos, M.V. (María Victoria), Lahuerta, J.J. (Juan José), San-Miguel, J.F. (Jesús F.)
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
The value of minimal residual disease (MRD) in multiple myeloma (MM) has been more frequently investigated in transplant-eligible than elderly patients. Since an optimal balance between treatment efficacy and toxicity is of utmost importance in elder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8f763f88dd6d0f6fa0d843a67f7c971e
https://hdl.handle.net/10171/52177
https://hdl.handle.net/10171/52177
Autor:
Mateos, M.V. (María Victoria), Cibeira, M. (M.T.), Richardson, P.G. (Paul G.), Prosper, F. (Felipe), Oriol, A. (Albert), Rubia, J. (Javier) de la, Lahuerta, J.J. (Juan José), García-Sanz, R. (Ramón), Extremera, S. (S.), Szyldergemajn, S. (Sergio), Corrado, C. (C.), Singer, H. (H.), Mitsiades, C.S. (Constantine S.), Anderson, K.C. (K.C.), Bladé, J. (Joan), San-Miguel, J.F. (Jesús F.)
Purpose: This trial evaluated the antitumor activity and safety of the marine-derived cyclodepsipeptide plitidepsin in patients with relapsed/refractory multiple myeloma. Experimental Design: This was a prospective, multicenter, open-label, single-ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::940b8e22d17137e42c2fcd19b2e4bf17
https://hdl.handle.net/10171/18157
https://hdl.handle.net/10171/18157
Autor:
Rodriguez, J. (José), Conde, E. (Eulogio), Gutierrez, A. (Antonio), Lahuerta, J.J. (Juan José), Arranz, R. (R.), Sureda, A. (Anna), Zuazu, J. (Javier), Fernandez-de-Sevilla, A. (A.), Bendandi, M. (Maurizio), Solano, C. (C.), Leon, A. (Angel), Varela, M.R. (María Rosario), Caballero, M.D. (M.D.), Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL-TAMO)
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
instname
BACKGROUND AND OBJECTIVES: Preliminary data on the use of autologous stem cell transplantation (ASCT) as a salvage therapy for peripheral T-cell lymphoma (PTCL) indicate that the results are similar to those obtained in aggressive B-cell lymphomas. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::49acfe3677f1de618b83ba91aeeb8154
https://hdl.handle.net/10171/20025
https://hdl.handle.net/10171/20025